Artiva Biotherapeutics (ARTV) FCF Margin (2023 - 2024)
Artiva Biotherapeutics (ARTV) reported FCF Margin of -22180.88% for FY2024, down 22029.53 percentage points from -151.34% in FY2023.
Powered by 
Analysis
Artiva Biotherapeutics (ARTV) FCF Margin (2023 - 2024) Analysis & Trends
- According to Business Quant data, FCF Margin came in at -151.34% in FY2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 28.82% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 18.33% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 26.96% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 43.05% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 34.72% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 34.70% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 44.00% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.01% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 30.39% |
| 10 | Artiva Biotherapeutics | 277.08 Mn | 277.08 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | -6,017.53% |
| Dec 31, 2023 | -481.32% |
| Sep 30, 2023 | -40.99% |
API Access
Artiva Biotherapeutics FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=ARTV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "ARTV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=ARTV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();